help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monzani, F.
Right arrow Articles by Ferrannini, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monzani, F.
Right arrow Articles by Ferrannini, E.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 5 2099-2106
Copyright © 2004 by The Endocrine Society

Effect of Levothyroxine Replacement on Lipid Profile and Intima-Media Thickness in Subclinical Hypothyroidism: A Double-Blind, Placebo- Controlled Study

F. Monzani, N. Caraccio, M. Kozàkowà, A. Dardano, F. Vittone, A. Virdis, S. Taddei, C. Palombo and E. Ferrannini

Department of Internal Medicine and National Research Council Institute of Clinical Physiology, University of Pisa, Pisa 56126, Italy

Address all correspondence and requests for reprints to: Fabio Monzani, M.D., Metabolism Unit, Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy. E-mail: fmonzani{at}med.unipi.it.

Subclinical hypothyroidism (sHT) is associated with dyslipidemia and enhanced cardiovascular risk. We assessed carotid artery intima-media thickness (IMT, high-resolution ultrasonography) and lipoprotein profile in 45 sHT patients (aged 37 ± 11 yr) at baseline and after 6 months of randomized, placebo-controlled L-T4 replacement. In comparison with 32 age- and sex-matched controls, sHT patients had elevated total and low-density lipoprotein (LDL) cholesterol and ApoB levels (P = 0.002, P = 0.0007, and P = 0.01, respectively) and higher mean-IMT values (P < 0.0001). In stepwise regression analysis, mean-IMT was positively related (r2 = 0.71, P < 0.0001) to age, TSH, and LDL cholesterol. L-T4 replacement significantly reduced both total and LDL cholesterol (P < 0.0001 for both) and mean-IMT (by 11%, P < 0.0001). The decrement in IMT was directly related to the decrements of both total cholesterol and TSH (P = 0.02 and P = 0.0001, respectively). We conclude that early carotid artery wall alterations are present in sHT patients. Whether such IMT increase is related to an early atherosclerotic involvement of the arterial wall cannot be clearly decided on the basis of the present results. However, the fact that L-T4 replacement therapy was able to improve both the atherogenic lipoprotein profile and intima-media thickening suggests that lipid infiltration of arterial wall may represent a major mechanism underlying IMT increase in subclinical hypothyroidism.

The study was partly presented at the Annual Meeting of the European Thyroid Association, Edinburgh, United Kingdom, October 18–22, 2003.

Abbreviations: ApoA1, Apolipoprotein A1; ApoB, apolipoprotein B; BMI, body mass index; CI, confidence interval; FT3, free T3; FT4, free T4; IMT, intima-media thickness; IRMA, immunoradiometric assay; LDL, low-density lipoprotein; LDLc, LDL cholesterol; Lp(a), lipoprotein(a); L-T4, levothyroxine; sHT, subclinical hypothyroidism; TC, total cholesterol; TG, triglyceride; Tg-Ab, antithyroglobulin autoantibody; tHcy, total homocysteine; TPO-Ab, antithyroid peroxidase autoantibody; VSM, vascular smooth muscle.




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
U. Oliviero, A. Cittadini, G. Bosso, M. Cerbone, A. Valvano, D. Capalbo, V. Apuzzi, F. Calabrese, T. Lettiero, and M. Salerno
Effects of long-term L-thyroxine treatment on endothelial function and arterial distensibility in young adults with congenital hypothyroidism
Eur. J. Endocrinol., February 1, 2010; 162(2): 289 - 294.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
J. Klubo-Gwiezdzinska and L. Wartofsky
Thyrotropin Blood Levels, Subclinical Hypothyroidism, and the Elderly Patient
Arch Intern Med, November 23, 2009; 169(21): 1949 - 1951.
[Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
E. V. Krieger and R. H. Knopp
Hypothyroidism Misdiagnosed as Statin Intolerance
Ann Intern Med, July 7, 2009; 151(1): 72 - 72.
[Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
T. Nagasaki, M. Inaba, S. Yamada, K. Shirakawa, Y. Nagata, Y. Kumeda, Y. Hiura, H. Tahara, E. Ishimura, and Y. Nishizawa
Decrease of brachial-ankle pulse wave velocity in female subclinical hypothyroid patients during normalization of thyroid function: a double-blind, placebo-controlled study
Eur. J. Endocrinol., March 1, 2009; 160(3): 409 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Dorr, K. Empen, D. M Robinson, H. Wallaschofski, S. B Felix, and H. Volzke
The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area
Eur. J. Endocrinol., August 1, 2008; 159(2): 145 - 152.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Razvi, A. Shakoor, M. Vanderpump, J. U. Weaver, and S. H. S. Pearce
The Influence of Age on the Relationship between Subclinical Hypothyroidism and Ischemic Heart Disease: A Metaanalysis
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 2998 - 3007.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Salerno, U. Oliviero, T. Lettiero, V. Guardasole, D. M. Mattiacci, L. Saldamarco, D. Capalbo, A. Lucariello, L. Sacca, and A. Cittadini
Long-Term Cardiovascular Effects of Levothyroxine Therapy in Young Adults with Congenital Hypothyroidism
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2486 - 2491.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
N. Ochs, R. Auer, D. C. Bauer, D. Nanchen, J. Gussekloo, J. Cornuz, and N. Rodondi
Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ann Intern Med, June 3, 2008; 148(11): 832 - 845.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
B. O. Asvold, T. Bjoro, T. I. L. Nilsen, D. Gunnell, and L. J. Vatten
Thyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study
Arch Intern Med, April 28, 2008; 168(8): 855 - 860.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. Biondi and D. S. Cooper
The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev., February 1, 2008; 29(1): 76 - 131.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Berkenstam, J. Kristensen, K. Mellstrom, B. Carlsson, J. Malm, S. Rehnmark, N. Garg, C. M. Andersson, M. Rudling, F. Sjoberg, et al.
From the Cover: The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
PNAS, January 15, 2008; 105(2): 663 - 667.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. A. Spencer, J. G. Hollowell, M. Kazarosyan, and L. E. Braverman
National Health and Nutrition Examination Survey III Thyroid-Stimulating Hormone (TSH)-Thyroperoxidase Antibody Relationships Demonstrate That TSH Upper Reference Limits May Be Skewed by Occult Thyroid Dysfunction
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4236 - 4240.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Razvi, L. Ingoe, G. Keeka, C. Oates, C. McMillan, and J. U. Weaver
The Beneficial Effect of L-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1715 - 1723.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. J. D. Owen, C. Rajiv, D. Vinereanu, T. Mathew, A. G. Fraser, and J. H. Lazarus
Subclinical Hypothyroidism, Arterial Stiffness, and Myocardial Reserve
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2126 - 2132.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Nagasaki, M. Inaba, Y. Kumeda, Y. Hiura, K. Shirakawa, S. Yamada, Y. Henmi, E. Ishimura, and Y. Nishizawa
Increased Pulse Wave Velocity in Subclinical Hypothyroidism
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 154 - 158.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
N. Rodondi, A. B. Newman, E. Vittinghoff, N. de Rekeneire, S. Satterfield, T. B. Harris, and D. C. Bauer
Subclinical Hypothyroidism and the Risk of Heart Failure, Other Cardiovascular Events, and Death
Arch Intern Med, November 28, 2005; 165(21): 2460 - 2466.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
L. Wartofsky
Update in Endocrinology
Ann Intern Med, November 1, 2005; 143(9): 673 - 682.
[Full Text] [PDF]

Home page
 StrokeHome page
A. Squizzato, V.E.A. Gerdes, D.P.M. Brandjes, H.R. Buller, and J. Stam
Thyroid Diseases and Cerebrovascular Disease
Stroke, October 1, 2005; 36(10): 2302 - 2310.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Wartofsky and R. A Dickey
The Evidence for a Narrower Thyrotropin Reference Range Is Compelling
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5483 - 5488.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. I. Surks, G. Goswami, and G. H. Daniels
The Thyrotropin Reference Range Should Remain Unchanged
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5489 - 5496.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
L. Wartofsky
Levothyroxine Therapy for Hypothyroidism: Should We Abandon Conservative Dosage Titration?
Arch Intern Med, August 8, 2005; 165(15): 1683 - 1684.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. J. Diez, P. Iglesias, and K. D. Burman
Spontaneous Normalization of Thyrotropin Concentrations in Patients with Subclinical Hypothyroidism
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4124 - 4127.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. I. Surks
Subclinical Thyroid Disease and Cardiovascular Disease--Reply
JAMA, March 2, 2005; 293(9): 1060 - 1060.
[Full Text] [PDF]

Home page
 JAMAHome page
N. Caraccio, A. Dardano, and F. Monzani
Subclinical Thyroid Disease and Cardiovascular Disease
JAMA, March 2, 2005; 293(9): 1059 - 1060.
[Full Text] [PDF]

Home page
 JAMAHome page
D. S. Cooper
Thyroid Disease in the Oldest Old: The Exception to the Rule
JAMA, December 1, 2004; 292(21): 2651 - 2654.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society